Recent Finacing
Recent Raise
다임바이오 is a biotech company developing next-generation PARP-1 oncology drugs and novel therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
Focus Areas
Total Raised
Funding round
